TETRALOGIC PHARMACEUTICALS CORP Operating Income
TETRALOGIC PHARMACEUTICALS CORP reported Operating Income of -$9.22 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2016-11-03
- TETRALOGIC PHARMACEUTICALS CORP operating income (loss) for the quarter ending 2016-09-30 was -$9.22M.
- TETRALOGIC PHARMACEUTICALS CORP operating income (loss) for the quarter ending 2016-06-30 was -$5.02M.
- TETRALOGIC PHARMACEUTICALS CORP operating income (loss) for the quarter ending 2016-03-31 was -$9.34M.
- TETRALOGIC PHARMACEUTICALS CORP operating income (loss) for the quarter ending 2015-12-31 was -$12.94M.
- TETRALOGIC PHARMACEUTICALS CORP operating income (loss) for fiscal 2015 was -$44.99M.
- TETRALOGIC PHARMACEUTICALS CORP operating income (loss) for fiscal 2014 was -$33.79M.
- TETRALOGIC PHARMACEUTICALS CORP operating income (loss) for fiscal 2013 was -$17.99M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 126 month |
|---|---|---|---|---|---|
| 2016-09-30 | -$9.22M 10-Q · filed 2016-11-03 | -$14.24M derived: sum of 2 quarters · filed 2016-11-03 | -$23.58M 10-Q · filed 2016-11-03 | -$36.53M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-06-30 | -$5.02M 10-Q · filed 2016-08-11 | -$14.36M 10-Q · filed 2016-08-11 | -$27.30M derived: sum of 3 quarters · filed 2016-08-11 | -$37.04M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2016-03-31 | -$9.34M 10-Q · filed 2016-05-04 | -$22.28M derived: sum of 2 quarters · filed 2016-05-04 | -$32.03M derived: sum of 3 quarters · filed 2016-11-03 | -$43.70M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-12-31 | -$12.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | -$22.69M derived: sum of 2 quarters · filed 2016-11-03 | -$34.36M derived: sum of 3 quarters · filed 2016-11-03 | -$44.99M 10-K · filed 2016-03-16 | |
| 2015-09-30 | -$9.74M 10-Q · filed 2016-11-03 | -$21.42M derived: sum of 2 quarters · filed 2016-11-03 | -$32.05M 10-Q · filed 2016-11-03 | -$41.84M derived: sum of 4 quarters · filed 2016-11-03 | |
| 2015-06-30 | -$11.67M 10-Q · filed 2016-08-11 | -$22.30M 10-Q · filed 2016-08-11 | -$32.10M derived: sum of 3 quarters · filed 2016-08-11 | -$41.67M derived: sum of 4 quarters · filed 2016-08-11 | |
| 2015-03-31 | -$10.63M 10-Q · filed 2016-05-04 | -$20.42M derived: sum of 2 quarters · filed 2016-05-04 | -$30.00M derived: sum of 3 quarters · filed 2016-05-04 | -$38.78M derived: sum of 4 quarters · filed 2016-05-04 | |
| 2014-12-31 | -$9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | -$19.37M derived: sum of 2 quarters · filed 2016-03-16 | -$28.15M derived: sum of 3 quarters · filed 2016-03-16 | -$33.79M 10-K · filed 2016-03-16 | |
| 2014-09-30 | -$9.58M 10-Q · filed 2015-11-04 | -$18.36M derived: sum of 2 quarters · filed 2015-11-04 | -$23.99M 10-Q · filed 2015-11-04 | -$31.40M derived: sum of 4 quarters · filed 2015-11-04 | |
| 2014-06-30 | -$8.79M 10-Q · filed 2015-08-05 | -$14.42M 10-Q · filed 2015-08-05 | -$21.82M derived: sum of 3 quarters · filed 2015-08-05 | -$26.14M derived: sum of 4 quarters · filed 2015-08-05 | |
| 2014-03-31 | -$5.63M 10-Q · filed 2015-05-14 | -$13.04M derived: sum of 2 quarters · filed 2015-05-14 | -$17.36M derived: sum of 3 quarters · filed 2015-05-14 | -$20.40M derived: sum of 4 quarters · filed 2015-05-14 | -$94.18M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$11.73M derived: sum of 2 quarters · filed 2015-02-26 | -$14.77M derived: sum of 3 quarters · filed 2015-02-26 | -$17.99M 10-K · filed 2015-02-26 | |
| 2013-09-30 | -$4.32M 10-Q · filed 2014-11-05 | -$7.36M derived: sum of 2 quarters · filed 2014-11-05 | -$10.59M 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | -$3.04M 10-Q · filed 2014-08-05 | -$6.26M 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | -$3.22M 10-Q · filed 2014-05-08 |